The proof is clearly in the sales. NCCN guidelines were supposedly the holy grail and look where we are, back where we began. The playing field has shifted and the market no longer cares about what “might” happen, it only cares what is happening. Until we get significant sales (like that big order for 20) I don’t think we will move the needle. Just my 2c worth. I bought into the hype and learnt a big lesson. Reality is the only thing that matters. Lives covered is great in theory but not without SOZO machines to test patients.
Add to My Watchlist
What is My Watchlist?
